- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 172.32M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.32M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.61M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $94.71K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $709.62K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.71M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.42M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.69M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.51M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.69M |
| Stock Issued | Q1 2025 · Mar 31, 2024 | 270K sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 172.08M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $4.64M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $5.28M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $514.46K |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $260.36K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$684.71K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$774.82K |